Compound details
Heteroflavanone A
| Compound ID | CDAMM00591 |
|---|---|
| Common name | Heteroflavanone A | IUPAC name | 5-hydroxy-7-methoxy-2-(2,4,6-trimethoxyphenyl)-2,3-dihydrochromen-4-one |
| Molecular formula | C19H20O7 |
| Retention time | 14.68 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 361.131 | Theoretical mz | 361.128 |
| Error | 6.71 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.377 |
| Inchi key | JEXUYOSYJIRTIF-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1C=2C(O)=CC(OC)=CC2OC(C=3C(OC)=CC(OC)=CC3OC)C1 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P22303 | ACHE | Acetylcholinesterase | T30082 | SwissTargetPrediction |
| P36544 | CHRNA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | T34429 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SwissTargetPrediction |
| Q07820 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | T14912 | SwissTargetPrediction |
| P09874 | PARP1 | Poly [ADP-ribose] polymerase-1 | T06273 | SwissTargetPrediction |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| P14555 | PLA2G2A | Phospholipase A2 group IIA | T19160 | SwissTargetPrediction |
| P04054 | PLA2G1B | Phospholipase A2 group 1B | T31479 | SwissTargetPrediction |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SwissTargetPrediction |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SwissTargetPrediction |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction and SEA |
| P07949 | RET | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET | T60631 | SwissTargetPrediction |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction |
| Q9UQL6 | HDAC5 | Histone deacetylase 5 | T07930 | SwissTargetPrediction |
| P23141 | CES1 | Acyl coenzyme A:cholesterol acyltransferase | T76369 | SwissTargetPrediction |
| Q5T7T8 | COX1 | Prostaglandin G/H synthase 1 | T60529 | SwissTargetPrediction |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SwissTargetPrediction |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction and SEA |
| Q9NYA1 | SPHK1 | Sphingosine kinase 1 | T86014 | SwissTargetPrediction |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SwissTargetPrediction |
| P08254 | MMP3 | Matrix metalloproteinase 3 | T86702 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SwissTargetPrediction |
| P05121 | SERPINE1 | Plasminogen activator inhibitor-1 | T15556 | SwissTargetPrediction |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P54760 | EPHB4 | Ephrin receptor | T49507 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P42345 | MTOR | Serine/threonine-protein kinase mTOR | T75243 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| P30291 | WEE1 | Serine/threonine-protein kinase WEE1 | T69991 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| P56817 | BACE1 | Beta-secretase 1 | T79031 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P09237 | MMP7 | Matrix metalloproteinase 7 | T73475 | SwissTargetPrediction |
| P13497 | BMP1 | Bone morphogenetic protein 1 | T53350 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SEA |
| P37231 | PPARG | Peroxisome proliferator-activated receptor gamma | T58921 | SwissTargetPrediction |
| O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | T01003 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P47871 | GCGR | Glucagon receptor | T60182 | SwissTargetPrediction |
| P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | T63966 | SwissTargetPrediction |
| Q9HBH9 | MKNK2 | MAP kinase signal-integrating kinase 2 | T99160 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P06870 | KLK1 | Kallikrein 1 | T40000 | SwissTargetPrediction |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SwissTargetPrediction and SEA |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SwissTargetPrediction |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| P39900 | MMP12 | Matrix metalloproteinase 12 | T03500 | SwissTargetPrediction |
| P31639 | SLC5A2 | Sodium/glucose cotransporter 2 | T30085 | SwissTargetPrediction |
| P25025 | CXCR2 | Interleukin-8 receptor B | T56923 | SwissTargetPrediction |
| P19793 | RXRA | Retinoid X receptor alpha (by homology) | T13726 | SwissTargetPrediction |
| P53350 | PLK1 | Serine/threonine-protein kinase PLK1 | T40694 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction and SEA |
| P37023 | ACVRL1 | Serine/threonine-protein kinase receptor R3 | T36959 | SEA |
| P16234 | PDGFRA | Platelet-derived growth factor receptor | T53524 | SEA |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SwissTargetPrediction |
| P19525 | EIF2AK2 | Interferon-induced, double-stranded RNA-activated protein kinase | T04831 | SwissTargetPrediction |
| Q9HCP0 | CSNK1G1 | Casein kinase I gamma 1 | T41702 | SwissTargetPrediction |
| Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha 1 | T83202 | SwissTargetPrediction |
| P29323 | EPHB2 | Ephrin type-B receptor 2 | T73756 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SwissTargetPrediction and SEA |
| O14672 | ADAM10 | ADAM10 | T31902 | SwissTargetPrediction |
| Q9NRA0 | SPHK2 | Sphingosine kinase 2 | T31989 | SwissTargetPrediction |
| P51512 | MMP16 | Matrix metalloproteinase 16 | T35824 | SwissTargetPrediction |
| Q08493 | PDE4C | Phosphodiesterase 4C | T12081 | SwissTargetPrediction |
| P51511 | MMP15 | Matrix metalloproteinase 15 | T81658 | SwissTargetPrediction |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SwissTargetPrediction and SEA |
| Q9NZ70 | TAK1 | TGF-beta-activated kinase 1 | T04361 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T30082 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P22303 | ACHE |
| T30082 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22303 | ACHE |
| T30082 | DI0282 | Myasthenia gravis | [ICD-11: 8C6Y] | P22303 | ACHE |
| T30082 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P22303 | ACHE |
| T30082 | DI0332 | Pediculosis | [ICD-11: 1G00] | P22303 | ACHE |
| T30082 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P22303 | ACHE |
| T34429 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P36544 | CHRNA7 |
| T34429 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P36544 | CHRNA7 |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T14912 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q07820 | MCL1 |
| T14912 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q07820 | MCL1 |
| T14912 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q07820 | MCL1 |
| T14912 | DI0252 | Melanoma | [ICD-11: 2C30] | Q07820 | MCL1 |
| T14912 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q07820 | MCL1 |
| T14912 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q07820 | MCL1 |
| T06273 | DI0006 | Acquired cutaneous blood vessel malformation | [ICD-11: EF20] | P09874 | PARP1 |
| T06273 | DI0143 | Fallopian tube cancer | [ICD-11: 2C74] | P09874 | PARP1 |
| T06273 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P09874 | PARP1 |
| T06273 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P09874 | PARP1 |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T19160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P14555 | PLA2G2A |
| T31479 | DI0230 | Leishmaniasis | [ICD-11: 1F54] | P04054 | PLA2G1B |
| T31479 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P04054 | PLA2G1B |
| T31479 | DI0367 | Rosacea | [ICD-11: ED90] | P04054 | PLA2G1B |
| T31479 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P04054 | PLA2G1B |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T60631 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P07949 | RET |
| T60631 | DI0238 | Lung cancer | [ICD-11: 2C25] | P07949 | RET |
| T60631 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P07949 | RET |
| T60631 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P07949 | RET |
| T60631 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P07949 | RET |
| T60631 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P07949 | RET |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T76369 | DI0335 | Peroxisomal disease | [ICD-11: 5C57] | P23141 | CES1 |
| T76369 | DI0398 | Synthesis disorder | [ICD-11: 5C52-5C59] | P23141 | CES1 |
| T60529 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | Q5T7T8 | COX1 |
| T60529 | DI0145 | Female pelvic pain | [ICD-11: GA34] | Q5T7T8 | COX1 |
| T60529 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | Q5T7T8 | COX1 |
| T60529 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | Q5T7T8 | COX1 |
| T60529 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q5T7T8 | COX1 |
| T60529 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q5T7T8 | COX1 |
| T60529 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q5T7T8 | COX1 |
| T60529 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q5T7T8 | COX1 |
| T60529 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q5T7T8 | COX1 |
| T60529 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | Q5T7T8 | COX1 |
| T60529 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | Q5T7T8 | COX1 |
| T60529 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | Q5T7T8 | COX1 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T86014 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9NYA1 | SPHK1 |
| T86014 | DI0353 | Psychoactive substances use disorder | [ICD-11: 6C4G] | Q9NYA1 | SPHK1 |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T86702 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P08254 | MMP3 |
| T86702 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P08254 | MMP3 |
| T86702 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P08254 | MMP3 |
| T86702 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P08254 | MMP3 |
| T86702 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P08254 | MMP3 |
| T86702 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P08254 | MMP3 |
| T86702 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P08254 | MMP3 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T15556 | DI0037 | Asthma | [ICD-11: CA23] | P05121 | SERPINE1 |
| T15556 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P05121 | SERPINE1 |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T49507 | DI0060 | Brain cancer | [ICD-11: 2A00] | P54760 | EPHB4 |
| T49507 | DI0111 | Cystic/dysplastic kidney disease | [ICD-11: GB8Y] | P54760 | EPHB4 |
| T49507 | DI0238 | Lung cancer | [ICD-11: 2C25] | P54760 | EPHB4 |
| T49507 | DI0261 | Metastatic meninges neoplasm | [ICD-11: 2D51] | P54760 | EPHB4 |
| T49507 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P54760 | EPHB4 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T75243 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P42345 | MTOR |
| T75243 | DI0085 | Chronic myelomonocytic leukaemia | [ICD-11: 2A40] | P42345 | MTOR |
| T75243 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P42345 | MTOR |
| T75243 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P42345 | MTOR |
| T75243 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P42345 | MTOR |
| T75243 | DI0413 | Transplant rejection | [ICD-11: NE84] | P42345 | MTOR |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T69991 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P30291 | WEE1 |
| T69991 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30291 | WEE1 |
| T69991 | DI0429 | Uterine ligament/parametrium/uterine adnexa neoplasm | [ICD-11: 2C72] | P30291 | WEE1 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T79031 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P56817 | BACE1 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T73475 | DI0238 | Lung cancer | [ICD-11: 2C25] | P09237 | MMP7 |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T58921 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37231 | PPARG |
| T58921 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P37231 | PPARG |
| T58921 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P37231 | PPARG |
| T01003 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O75460 | ERN1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T60182 | DI0193 | Hypo-glycaemia | [ICD-11: 5A41] | P47871 | GCGR |
| T63966 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P17948 | FLT1 |
| T99160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9HBH9 | MKNK2 |
| T99160 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9HBH9 | MKNK2 |
| T99160 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9HBH9 | MKNK2 |
| T99160 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9HBH9 | MKNK2 |
| T99160 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9HBH9 | MKNK2 |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T03500 | DI0037 | Asthma | [ICD-11: CA23] | P39900 | MMP12 |
| T03500 | DI0238 | Lung cancer | [ICD-11: 2C25] | P39900 | MMP12 |
| T03500 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P39900 | MMP12 |
| T30085 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P31639 | SLC5A2 |
| T30085 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P31639 | SLC5A2 |
| T30085 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P31639 | SLC5A2 |
| T56923 | DI0155 | Fungal infection | [ICD-11: 1F29-1F2F] | P25025 | CXCR2 |
| T56923 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25025 | CXCR2 |
| T13726 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P19793 | RXRA |
| T13726 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P19793 | RXRA |
| T40694 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P53350 | PLK1 |
| T40694 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P53350 | PLK1 |
| T40694 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P53350 | PLK1 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T36959 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P37023 | ACVRL1 |
| T53524 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P16234 | PDGFRA |
| T53524 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P16234 | PDGFRA |
| T53524 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P16234 | PDGFRA |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T83202 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q15418 | RPS6KA1 |
| T73756 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P29323 | EPHB2 |
| T73756 | DI0252 | Melanoma | [ICD-11: 2C30] | P29323 | EPHB2 |
| T73756 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P29323 | EPHB2 |
| T73756 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P29323 | EPHB2 |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T31902 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O14672 | ADAM10 |
| T31989 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRA0 | SPHK2 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T04361 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q9NZ70 | TAK1 |